A cohort study on the biochemical and haematological parameters of Italian blood donors as possible risk factors of COVID-19 infection and severe disease in the pre- and post-Omicron period

PLoS One. 2023 Nov 21;18(11):e0294272. doi: 10.1371/journal.pone.0294272. eCollection 2023.

Abstract

To investigate the association between biochemical and blood parameters collected before the pandemic in a large cohort of Italian blood donors with the risk of infection and severe disease. We also focused on the differences between the pre- and post-Omicron spread in Italy (i.e., pre- and post-January 01, 2022) on the observed associations. We conducted an observational cohort study on 13750 blood donors was conducted using data archived up to 5 years before the pandemic. A t-test or chi-squared test was used to compare differences between groups. Hazard ratios with 95% confidence intervals for SARS-CoV-2 infection and severe disease were estimated using Cox proportional hazards models. Subgroup analyses stratified by sex, age and epidemic phase of first infection (pre- and post-Omicron spread) were examined. We confirmed a protective effect of groups B and O, while groups A and AB had a higher likelihood of infection and severe disease. However, these associations were only significant in the pre-Omicron period. We found an opposite behavior after Omicron spread, with the O phenotype having a higher probability of infection. When stratified by variant, A antigen appeared to protect against Omicron infection, whereas it was associated with an increased risk of infection by earlier variants. We were able to stratify for the SARS CoV-2 dominant variant, which revealed a causal association between blood group and probability of infection, as evidenced by the strong effect modification observed between the pre- and post-Omicron spread. The mechanism by which group A acts on the probability of infection should consider this strong effect modification.

Publication types

  • Observational Study

MeSH terms

  • Blood Donors
  • Blood Group Antigens*
  • COVID-19* / epidemiology
  • Cohort Studies
  • Humans
  • Italy / epidemiology
  • Pandemics
  • Risk Factors
  • SARS-CoV-2

Substances

  • Blood Group Antigens

Grants and funding

This study was partially supported by the Centro Regionale Sangue Emilia Romagna and by Italian Ministry of Health – Ricerca Corrente Annual Program 2024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.